Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Repeated ...

Rates of sustained IOP elevation in patients receiving anti-VEGF injections for wet age-related macular degeneration may be significant, with increased risks for those with glaucoma, a study suggested ...

Patients with age-related macular degeneration who received seven or more eye injections of the drug bevacizumab annually had a higher risk of having glaucoma surgery, according to a study. Patients ...

Presently, glaucoma is treated via daily-administered eye drops, surgery, or implanted devices – none of which are guaranteed to be successful. In the future, however, it's possible that a ...

This prospective, nonrandomized, consecutive cohort study aimed to assess 36-month outcomes after cataract surgery and implantation of two second-generation trabecular microbypass stents (iStent ...

eye surgery Study shows reductions in intraocular pressures and antiglaucoma medication use. Intravitreal bevacizumab administration improves outcomes, and may reduce both intraocular pressure (IOP) ...

The government of B.C. says injecting a drug into people's eyes to stave off blindness is safe and will continue despite the need for glaucoma surgery in some patients. A long and detailed news ...

A new study in mice has identified new treatment targets for glaucoma, including preventing a severe pediatric form of glaucoma, as well as uncovering a possible new class of therapy for the most ...

The FINANCIAL — Too much of a common age-related macular degeneration (AMD) treatment course in one year’s time could inadvertently tip the scales toward another sight-threatening disease, a new study ...